Anixa Biosciences Receives Notice Of Allowance From Mexican Institute of Industrial Property For New Patent Related To Its Breast Cancer Vaccine Technology

Anixa Biosciences, Inc. (NASDAQ: ANIX) has received a Notice of Allowance from the Mexican Institute of Industrial Property for a new patent related to its breast cancer vaccine technology, which is exclusively licensed from Cleveland Clinic. This patent provides composition of matter protection in Mexico, enhancing Anixa's international intellectual property portfolio and supporting its leadership in cancer immunotherapy. The new patent complements existing patents in the United States and other key global jurisdictions, aiding future regulatory and commercial efforts.